Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Telmisartan Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global telmisartan market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 3.5% during 2021-2026.

Telmisartan is a non-peptide angiotensin receptor blocker (ARB), which is used as a prescription drug for the treatment of hypertension and cardiovascular disorders. It is commonly available in tablets and oral oil suspension variants and is administered with other medications to enhance its efficacy. It exhibits antihypertensive properties and inhibits aldosterone production in the body, thereby leading to a decrease in sodium and water absorption and subsequent reduction in the blood pressure. Telmisartan also relaxes the blood vessels and promotes kidney function. However, it may cause various side effects, such as dizziness, lightheadedness, cough and sinus pain.

Telmisartan Market Trends:

Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, the increasing prevalence of high blood pressure, diabetes and various kidney-related disorders is providing a thrust to the market growth. Telmisartan has been proven effective in modifying genes for insulin sensitization and regulating glucose and lipid metabolism, which aids in managing chronic diabetic kidney disease and other disorders caused by sedentary lifestyles. Pharmaceutical manufacturers are also launching generic versions of telmisartan medications to provide cost-effective treatment to hypertension and cardiovascular ailments. Additionally, drug manufacturers are investing significantly in the research and development (R&D) of advanced telmisartan medications for the treatment of diabetic nephropathy, which is also contributing to the growth of the market. Other factors, including the rising geriatric population, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global telmisartan market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, indication and distribution channel.

Breakup by Indication:

  • Hypertension
  • Cardiovascular Risk Reduction
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Stores
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Aurobindo Pharma USA, Boehringer Ingelheim International GmbH , Cipla Limited, Hikma Pharmaceuticals plc, Jubilant Cadista Pharmaceutical, Sanofi S.A., Solco Healthcare (Prinston Pharmaceutical Inc.) and Torrent Pharmaceuticals Ltd.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Indication, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Aurobindo Pharma USA, Boehringer Ingelheim International GmbH , Cipla Limited, Hikma Pharmaceuticals plc, Jubilant Cadista Pharmaceutical, Sanofi S.A., Solco Healthcare (Prinston Pharmaceutical Inc.) and Torrent Pharmaceuticals Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global telmisartan market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global telmisartan market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global telmisartan market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Telmisartan Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Indication
    6.1    Hypertension
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Cardiovascular Risk Reduction
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Distribution Channel
    7.1    Hospital Pharmacies
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Drug Stores and Retail Pharmacies
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Online Stores
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abbott Laboratories
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Aurobindo Pharma USA
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
        13.3.3    Boehringer Ingelheim International GmbH 
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
        13.3.4    Cipla Limited
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Hikma Pharmaceuticals plc
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Jubilant Cadista Pharmaceutical
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
        13.3.7    Sanofi S.A.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Solco Healthcare (Prinston Pharmaceutical Inc.)
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
        13.3.9    Torrent Pharmaceuticals Ltd
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis

List of Figures

Figure 1: Global: Telmisartan Market: Major Drivers and Challenges
Figure 2: Global: Telmisartan Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Telmisartan Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Telmisartan Market: Breakup by Indication (in %), 2020
Figure 5: Global: Telmisartan Market: Breakup by Distribution Channel (in %), 2020
Figure 6: Global: Telmisartan Market: Breakup by Region (in %), 2020
Figure 7: Global: Telmisartan (Hypertension) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Telmisartan (Hypertension) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Telmisartan (Cardiovascular Risk Reduction) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Telmisartan (Cardiovascular Risk Reduction) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Telmisartan (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Telmisartan (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Telmisartan (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Telmisartan (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: North America: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: North America: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: United States: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: United States: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Canada: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Canada: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Asia-Pacific: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Asia-Pacific: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: China: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: China: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Japan: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Japan: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: India: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: India: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: South Korea: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: South Korea: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Australia: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Australia: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Indonesia: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Indonesia: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Others: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Others: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Europe: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Europe: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Germany: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Germany: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: France: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: France: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: United Kingdom: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: United Kingdom: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Italy: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Italy: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Spain: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Spain: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Russia: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Russia: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Others: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Others: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Latin America: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Latin America: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Brazil: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Brazil: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Mexico: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Mexico: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Middle East and Africa: Telmisartan Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Middle East and Africa: Telmisartan Market: Breakup by Country (in %), 2020
Figure 65: Middle East and Africa: Telmisartan Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Global: Telmisartan Industry: SWOT Analysis
Figure 67: Global: Telmisartan Industry: Value Chain Analysis
Figure 68: Global: Telmisartan Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Telmisartan Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Telmisartan Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 3: Global: Telmisartan Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 4: Global: Telmisartan Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Telmisartan Market: Competitive Structure
Table 6: Global: Telmisartan Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links